Keystone Financial Group (Kentucky)’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Keystone Financial Group (Kentucky)'s IBB Position: Q1 2026 in Review
Keystone Financial Group (Kentucky) reduced its iShares Biotechnology ETF (IBB) stake by 0.04% in Q1 2026, selling an estimated $171 and leaving 2,357 shares worth $398K. The position accounts for 0.03% of the portfolio, ranked #338.
Keystone Financial Group (Kentucky) first reported a position in IBB in Q2 2019 and has held it in 18 quarters since. The position peaked at $450K in Q2 2020. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Keystone Financial Group (Kentucky) held 2,357 shares of iShares Biotechnology ETF worth $398K as of Q1 2026.
- Keystone Financial Group (Kentucky) sold 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
- iShares Biotechnology ETF made up 0.03% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #338 holding.
- Keystone Financial Group (Kentucky) first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 18 quarters since.
- Keystone Financial Group (Kentucky)'s iShares Biotechnology ETF position peaked at $450K in Q2 2020.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.